Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: Correlation with cell cycle arrest and apoptosis

Nutrition and Cancer

Volumn 66, Issue 2, 2014, Pages 325-334

  Ferreira de Oliveira, José Miguel P ^a   Remédios, Catarina ^a   Oliveira, Helena ^a   Pinto, Pedro ^a   Pinho, Francisco ^a   Pinho, Sónia ^a   Costa, Maria ^a   Santos, Conceição ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; SULFORAPHANE; TRANSCRIPTOME;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL STRUCTURE; CELL VIABILITY; COMET ASSAY; CONCENTRATION RESPONSE; DNA DAMAGE; DRUG CYTOTOXICITY; FIBROBLAST; G2 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MICRONUCLEUS; MITOSIS; NUCLEAR DIVISION; OSTEOSARCOMA; OSTEOSARCOMA CELL; TREATMENT DURATION;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; COMET ASSAY; CYTOSKELETON; DNA DAMAGE; HUMANS; ISOTHIOCYANATES; MITOSIS; OSTEOSARCOMA;

EID: 84895085085     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.864777     Document Type: Article

References (57)

1. Stiller CA, Bielack SS, Jundt G, and Steliarova-Foucher E: Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42, 2124-2135, 2006.
2. Ham SJ, Schraffordt Koops H, van der Graaf WT, van Horn JR, Postma L, et al.: Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol 24, 584-600, 1998. (Pubitemid 28566909)
3. Gorlick R and Khanna C: Osteosarcoma. J Bone Miner Res 25, 683-691, 2010.
4. Ta HT, Dass CR, Larson I, Choong PFM, and Dunstan DE: A chitosandipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials 30, 3605-3613, 2009.
5. Posthuma DeBoer J, Witlox MA, Kaspers GJL, and van Royen BJ: Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastas 28, 493-503, 2011.
6. Wachtel M and Schafer BW: Targets for cancer therapy in childhood sarcomas. Cancer Treat Rev 36, 318-327, 2010.
7. Broadhead ML, Clark JC, Myers DE, Dass CR, and Choong PF: The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011, 959248, 1-12, 2011.
8. Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, et al.: Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res 64, 456-463, 2011.
9. Gasper AV, Al-janobi A, Smith JA, Bacon JR, Fortun P, et al.: Glutathione S-transferase M1 polymorphism andmetabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82, 1283-1291, 2005. (Pubitemid 43779728)
10. Brooks JD, Paton VG, and Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 10, 949-954, 2001. (Pubitemid 32844902)
11. Morimitsu Y, Nakagawa Y, Hayashi K, Fujii H, Kumagai T, et al.: A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem 277, 3456-3463, 2002. (Pubitemid 34953214)
12. Huang TY, Chang WC, Wang MY, Yang YR, and Hsu YC: Effect of sulforaphane on growth inhibition in human brain malignant glioma GBM 8401 cells by means of mitochondrial- and MEK/ERK-mediated apoptosis pathway. Cell Biochem Biophys 63, 247-259, 2012.
13. Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, et al.: Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate. Mol Ther 19, 188-195, 2011.
14. Kanematsu S, Yoshizawa K, Uehara N, Miki H, Sasaki T, et al.: Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep 26, 603-608, 2011.
15. Li YY, Zhang T, Korkaya H, Liu SL, Lee HF, et al.: Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 16, 2580-2590, 2010.
16. Rausch V, Liu L, Kallifatidis G, Baumann B, Mattern J, et al.: Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics. Cancer Res 70, 5004-5013, 2010.
17. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, et al.: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279, 25813-25822, 2004. (Pubitemid 38756846)
18. Herman-Antosiewicz A, Xiao H, Lew KL, and Singh SV: Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Mol Cancer Ther 6, 1673-1681, 2007. (Pubitemid 46954034)
19. Kim MR, Zhou L, Park BH, and Kim JR: Induction of G(2)/M arrest and apoptosis by sulforaphane in human osteosarcoma U2-OS cells. Mol Med Rep 4, 929-934, 2011.
20. Shen G, Xu C, Chen C, Hebbar V, and Kong AN: p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 57, 317-327, 2006.
21. Suppipat K, Park CS, Shen Y, Zhu X, and Lacorazza HD: Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS One 7, e51251, 2012.
22. Matsui TA, Murata H, Sakabe T, Sowa Y, Horie N, et al.: Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. Oncol Rep 18, 1263-1268, 2007.
23. Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, et al.: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 20, 631-636, 2002.
24. Fimognari C, Berti F, Iori R, Cantelli-Forti G, and Hrelia P: Micronucleus formation and induction of apoptosis by different isothiocyanates and a mixture of isothiocyanates in human lymphocyte cultures. Mutat Res-Gen Tox En 582, 1-10, 2005. (Pubitemid 40386915)
25. Fimognari C, Berti F, Cantelli-Forti G, and Hrelia P: Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ Mol Mutagen 46, 260-267, 2005. (Pubitemid 43107947)
26. Tope AM and Rogers PF: Evaluation of protective effects of sulforaphane on DNA damage caused by exposure to low levels of pesticide mixture using comet assay. J Environ Sci Heal B 44, 657-662, 2009.
27. Barcelo S, Gardiner JM, Gescher A, and Chipman JK: CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17, 277-282, 1996. (Pubitemid 26091306)
28. Gross-Steinmeyer K, Stapleton PL, Tracy JH, Bammler TK, Strom SC, et al.: Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci 116, 422- 432, 2010.
29. Bonnesen C, Eggleston IM, and Hayes JD: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61, 6120-6130, 2001. (Pubitemid 32762548)
30. Rudolf E and Cervinka M: Sulforaphane induces cytotoxicity and lysosomeand mitochondria-dependent cell death in colon cancer cells with deleted p53. Toxicol in Vitro 25, 1302-1309, 2011.
31. Cho SD, Li G, Hu H, Jiang C, Kang KS, et al.: Involvement of c-Jun Nterminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer 52, 213-224, 2005. (Pubitemid 41579763)
32. Rudolf E, Andelova H and Cervinka M: Activation of several concurrent proapoptic pathways by sulforaphane in human colon cancer cells SW620. Food Chem Toxicol 47, 2366-2373, 2009.
33. Sekine-Suzuki E, Yu D, Kubota N, Okayasu R, and Anzai K: Sulforaphane induces DNA double strand breaks predominantly repaired by homologous recombination pathway in human cancer cells. Biochem Bioph Res Co 377, 341-345, 2008.
34. Sestili P, Paolillo M, Lenzi M, Colombo E, Vallorani L, et al.: Sulforaphane induces DNA single strand breaks in cultured human cells. Mutat Res-Fund Mol M 689, 65-73, 2010.
35. Twentyman PR and Luscombe M. 1987. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56, 279-285, 1987. (Pubitemid 17158816)
36. Misra RK and Easton MD: Comment on analyzing flow cytometric data for comparison of mean values of the coefficient of variation of the G1 peak. Cytometry 36, 112-116, 1999. (Pubitemid 29247123)
37. Rozen S and Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365-386, 2000.
38. Zhao S and Fernald RD: Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12, 1047- 1064, 2005. (Pubitemid 41580022)
39. Pfaffl MW: A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29, e45, 2001.
40. Singh NP, McCoy MT, Tice RR, and Schneider EL: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175, 184-191, 1988.
41. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, et al.: Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35, 206-221, 2000. (Pubitemid 30196665)
42. Fenech M: Cytokinesis-block micronucleus cytome assay. Nat Protoc 2, 1084-1104, 2007. (Pubitemid 46901289)
43. Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, et al.: Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23, 581-586, 2002. (Pubitemid 34498494)
44. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, et al.: Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. Toxicol Appl Pharmacol 235, 57-67, 2009.
45. Matsui TA, Sowa Y, Yoshida T, Murata H, Horinaka M, et al.: Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. Carcinogenesis 27, 1768- 1777, 2006. (Pubitemid 44288659)
46. Sawai Y, Murata H, Horii M, Koto K, Matsui T, et al.: Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells. Oncology Reports 29, 941-945, 2013.
47. Boutros R, Lobjois V, and Ducommun B: CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 7, 495-507, 2007. (Pubitemid 46985396)
48. Medema RH and Macurek L: Checkpoint control and cancer. Oncogene 31, 2601-2613, 2012.
49. Jackson SJ and Singletary KW: Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr 134, 2229-2236, 2004. (Pubitemid 39201590)
50. Jackson SJ and Singletary KW: Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25, 219-227, 2004. (Pubitemid 38239805)
51. Jackson SJ, Singletary KW, and Venema RC: Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol 46, 77-84, 2007. (Pubitemid 44937679)
52. Azarenko O, Okouneva T, Singletary KW, Jordan MA, and Wilson L: Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Carcinogenesis 29, 2360-2368, 2008.
53. Mi L, Xiao Z, Hood BL, Dakshanamurthy S, Wang X, et al.: Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem 283, 22136-22146, 2008.
54. Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer 10, 68, 2011.
55. Mi L, Hood BL, Stewart NA, Xiao Z, Govind S, et al.: Identification of potential protein targets of isothiocyanates by proteomics. Chem Res Toxicol 24, 1735-1743, 2011.
56. Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, et al.: Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 26, 125-132, 2011.
57. Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, et al.: Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet 144, 91-99, 2003. (Pubitemid 36808954)